FDA Grants Accelerated Approval to Replimune Melanoma Therapy

By Elaine Chen · STAT News · 2026-08-06

FDA Grants Accelerated Approval to Replimune Melanoma Therapy

The Food and Drug Administration has authorized Replimune’s oncolytic immunotherapy for patients with advanced melanoma following a series of regulatory setbacks. According to reporting from STAT News, the treatment will be sold under the brand name Tudriqev after an advisory com

The Food and Drug Administration has authorized Replimune’s oncolytic immunotherapy for patients with advanced melanoma following a series of regulatory setbacks. According to reporting from STAT News, the treatment will be sold under the brand name Tudriqev after an advisory com